News
- Author:
- Bruce Jancin
Publish date: August 28, 2020
“The big thing is to look for and treat the underlying precipitating event.”
News
- Author:
- Bruce Jancin
Publish date: August 26, 2020
“I really like this H2FPEF score. The score works very, very well” for diagnosis of HFpEF – Dr. Dustin T. Smith
News
- Author:
- Bruce Jancin
Publish date: August 26, 2020
Continuous therapy is warranted to prevent recurrences.
News
- Author:
- Bruce Jancin
Publish date: August 24, 2020
Dersimelagon increases cutaneous melanin density.
News
- Author:
- Bruce Jancin
Publish date: August 21, 2020
“This is something we’re going to see more frequently, and many of us already have.”
News
- Author:
- Bruce Jancin
Publish date: August 20, 2020
“The applicability of clinical trials data to hospitalized patients is generally poor. That’s an important caveat to keep in mind.”
News
- Author:
- Bruce Jancin
Publish date: August 19, 2020
DAXI is under regulatory review for treatment of glabellar lines.
News
- Author:
- Bruce Jancin
Publish date: August 14, 2020
“I think if I had to pick the one thing that drives my decision the most about whether someone needs more aggressive therapy than anticoagulation, ...
News
- Author:
- Bruce Jancin
Publish date: August 13, 2020
Ask these three questions about the EKG to quickly arrive at the right diagnosis.
News
- Author:
- Bruce Jancin
Publish date: August 13, 2020
Be selective in ordering cardiac biomarker tests for COVID-19 patients, cardiologist advises.
News
- Author:
- Bruce Jancin
Publish date: August 12, 2020
The novel technology, coronary CT angiography–derived fractional flow reserve, speeds the TAVR patient’s diagnostic journey.
News
- Author:
- Bruce Jancin
Publish date: August 10, 2020
A PASI 100 response, traditionally considered unreachable for most patients with severe psoriasis, soon just might not be good enough.
News
- Author:
- Bruce Jancin
Publish date: August 5, 2020
International survey finds most interventional cardiologists consider angiographic appearance alone sufficient to decide significance of coronary s...
News
- Author:
- Bruce Jancin
Publish date: August 5, 2020
Positive phase 3 results reported for two prescription topical agents for primary axillary hyperhidrosis.
News
- Author:
- Bruce Jancin
Publish date: July 29, 2020
Ninety-three percent of patients had no mitral regurgitation at 2 years in the Tendyne Expanded Clinical Study.
